这是一篇来自已证抗体库的有关人类 HLA-DQB1 (HLA-DQB1) 的综述,是根据23篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合HLA-DQB1 抗体。
HLA-DQB1 同义词: CELIAC1; HLA-DQB; IDDM1; HLA class II histocompatibility antigen, DQ beta 1 chain; MHC class II DQ beta chain; MHC class II HLA-DQ beta glycoprotein; MHC class II antigen DQB1; MHC class II antigen HLA-DQ-beta-1

BioLegend
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠; 1:400; 图 s3c
BioLegendHLA-DQB1抗体(Biolegend, 116422)被用于被用于流式细胞仪在小鼠样品上浓度为1:400 (图 s3c). Nat Commun (2018) ncbi
小鼠 单克隆(AF6-120.1)
  • 免疫组化; 小鼠; 图 5f
BioLegendHLA-DQB1抗体(Biolegend, 116406)被用于被用于免疫组化在小鼠样品上 (图 5f). J Clin Invest (2018) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠; 图 s4d
BioLegendHLA-DQB1抗体(Biolegend, AF6-120.1)被用于被用于流式细胞仪在小鼠样品上 (图 s4d). Eur J Immunol (2018) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠; 图 1b
BioLegendHLA-DQB1抗体(biolegend, AF6-120.1)被用于被用于流式细胞仪在小鼠样品上 (图 1b). J Exp Med (2017) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠; 1:100; 图 s8
BioLegendHLA-DQB1抗体(BioLegend, 116419)被用于被用于流式细胞仪在小鼠样品上浓度为1:100 (图 s8). Nat Commun (2016) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DQB1抗体(BioLegend, Tu39)被用于被用于流式细胞仪在人类样品上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠; 图 3c
BioLegendHLA-DQB1抗体(Biolegend, 116416)被用于被用于流式细胞仪在小鼠样品上 (图 3c). J Virol (2016) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠; 图 s2f
BioLegendHLA-DQB1抗体(Biolegend, AF6-120.1)被用于被用于流式细胞仪在小鼠样品上 (图 s2f). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠; 图 2
BioLegendHLA-DQB1抗体(Biolegend, 116417)被用于被用于流式细胞仪在小鼠样品上 (图 2). Oncoimmunology (2015) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类
BioLegendHLA-DQB1抗体(Biolegend, #361703)被用于被用于流式细胞仪在人类样品上. Am J Transplant (2015) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠
BioLegendHLA-DQB1抗体(BioLegend, 116422)被用于被用于流式细胞仪在小鼠样品上. Cardiovasc Res (2015) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠; 图 s4
BioLegendHLA-DQB1抗体(Biolegend, 116408)被用于被用于流式细胞仪在小鼠样品上 (图 s4). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠
BioLegendHLA-DQB1抗体(BioLegend, AF6-120.1)被用于被用于流式细胞仪在小鼠样品上. PLoS ONE (2014) ncbi
小鼠 单克隆(AF6-120.1)
  • 流式细胞仪; 小鼠
BioLegendHLA-DQB1抗体(BioLegend, AF-6-120.1)被用于被用于流式细胞仪在小鼠样品上. Blood (2014) ncbi
小鼠 单克隆(HLADQ1)
BioLegendHLA-DQB1抗体(BioLegend, 318105)被用于. J Immunol (2014) ncbi
美天旎
人类 重组(REA332)
  • 流式细胞仪; 人类; 图 s3j
美天旎HLA-DQB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样品上 (图 s3j). Biol Blood Marrow Transplant (2018) ncbi
人类 重组(REA332)
  • 流式细胞仪; 人类; 图 st1
美天旎HLA-DQB1抗体(Miltenyi, REA332)被用于被用于流式细胞仪在人类样品上 (图 st1). Front Immunol (2017) ncbi
人类 重组(REA332)
  • 流式细胞仪; 人类; 1:20; 图 6a
美天旎HLA-DQB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样品上浓度为1:20 (图 6a). J Immunol (2017) ncbi
人类 重组(REA332)
  • 流式细胞仪; 人类; 图 1a
美天旎HLA-DQB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样品上 (图 1a). Eur J Pharm Biopharm (2017) ncbi
人类 重组(REA332)
  • 流式细胞仪; 人类; 图 1
美天旎HLA-DQB1抗体(Miltenyi Biotec, REA332)被用于被用于流式细胞仪在人类样品上 (图 1). Inflammation (2016) ncbi
赛默飞世尔
小鼠 单克隆(CR3/43)
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 st2
赛默飞世尔HLA-DQB1抗体(Affinity Bioreagents, CR3/43)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:1000 (图 st2). Clin Cancer Res (2016) ncbi
小鼠 单克隆(CR3/43)
  • 免疫组化; 人类; 表 1
赛默飞世尔HLA-DQB1抗体(Affinity Bioreagents, MAI-25914)被用于被用于免疫组化在人类样品上 (表 1). Clin Cancer Res (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(B-K27)
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术HLA-DQB1抗体(SantaCruz, B-k-27)被用于被用于免疫印迹在人类样品上 (图 2a). Childs Nerv Syst (2017) ncbi
文章列表
  1. Wilgenburg B, Loh L, Chen Z, Pediongco T, Wang H, Shi M, et al. MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun. 2018;9:4706 pubmed 出版商
  2. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed 出版商
  3. Fan X, Guo D, Cheung A, Poon Z, Yap C, Goh S, et al. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2018;24:1971-1980 pubmed 出版商
  4. Purvis H, Clarke F, Jordan C, Blanco C, Cornish G, Dai X, et al. Protein tyrosine phosphatase PTPN22 regulates IL-1β dependent Th17 responses by modulating dectin-1 signaling in mice. Eur J Immunol. 2018;48:306-315 pubmed 出版商
  5. Delso Vallejo M, Kollet J, Koehl U, Huppert V. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property. Front Immunol. 2017;8:854 pubmed 出版商
  6. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed 出版商
  7. Borriello F, Iannone R, Di Somma S, Vastolo V, Petrosino G, Visconte F, et al. Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14+ CD1c+ Monocytes. J Immunol. 2017;198:3426-3435 pubmed 出版商
  8. Seif M, Hoppstädter J, Breinig F, Kiemer A. Yeast-mediated mRNA delivery polarizes immuno-suppressive macrophages towards an immuno-stimulatory phenotype. Eur J Pharm Biopharm. 2017;117:1-13 pubmed 出版商
  9. Das A, McDonald D, Lowe S, Bredlau A, Vanek K, Patel S, et al. Immunological low-dose radiation modulates the pediatric medulloblastoma antigens and enhances antibody-dependent cellular cytotoxicity. Childs Nerv Syst. 2017;33:429-436 pubmed 出版商
  10. Monnerat G, Alarcón M, Vasconcellos L, Hochman Mendez C, Brasil G, Bassani R, et al. Macrophage-dependent IL-1? production induces cardiac arrhythmias in diabetic mice. Nat Commun. 2016;7:13344 pubmed 出版商
  11. Seif M, Philippi A, Breinig F, Kiemer A, Hoppstädter J. Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype. Inflammation. 2016;39:1690-703 pubmed 出版商
  12. Wang Z, Milne K, Derocher H, Webb J, Nelson B, Watson P. CD103 and Intratumoral Immune Response in Breast Cancer. Clin Cancer Res. 2016;22:6290-6297 pubmed
  13. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  14. Anghelina D, Lam E, Falck Pedersen E. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity. J Virol. 2016;90:5915-27 pubmed 出版商
  15. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed 出版商
  16. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  17. Thomas K, Valenzuela N, Gjertson D, Mulder A, Fishbein M, Parry G, et al. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. Am J Transplant. 2015;15:2037-49 pubmed 出版商
  18. Wan W, Liu Q, Lionakis M, Marino A, Anderson S, Swamydas M, et al. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice. Cardiovasc Res. 2015;106:478-87 pubmed 出版商
  19. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed 出版商
  20. Å krnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed 出版商
  21. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed 出版商
  22. Uhlenbrock F, Hagemann Jensen M, Kehlet S, Andresen L, Pastorekova S, Skov S. The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway. J Immunol. 2014;193:1654-65 pubmed 出版商
  23. Wick D, Webb J, Nielsen J, Martin S, Kroeger D, Milne K, et al. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res. 2014;20:1125-34 pubmed 出版商